Neuroprotección de la Retina y Biomarcadores Moleculares en Superficie Ocular en Glaucoma
Instituto Oftalmologico de Alicante
Alicante, EspañaPublicaciones en colaboración con investigadores/as de Instituto Oftalmologico de Alicante (8)
2020
-
Genetic and environmental factors related to the development of myopic maculopathy in Spanish patients
PloS one, Vol. 15, Núm. 7, pp. e0236071
2018
-
Efficacy and safety of an aflibercept treat-and-extend regimen in treatment-naïve patients with macular oedema secondary to Central Retinal Vein Occlusion (CRVO): A Prospective 12-Month, Single-Arm, Multicentre Trial
Journal of Ophthalmology, Vol. 2018
-
Efficacy and safety of lampalizumab for geographic atrophy due to age-related macular degeneration: Chroma and spectri phase 3 randomized clinical trials
JAMA Ophthalmology, Vol. 136, Núm. 6, pp. 666-677
2015
-
Individualized Therapy with Ranibizumab in Wet Age-Related Macular Degeneration
Journal of Ophthalmology, Vol. 2015
2014
-
A Delphi study to detect deficiencies and propose actions in real life treatment of neovascular age-related macular degeneration
Journal of Ophthalmology, Vol. 2014
2013
-
Spectral-domain optical coherence tomography study of macular structure as prognostic and determining factor for macular hole surgery outcome
Retina, Vol. 33, Núm. 6, pp. 1117-1122
2012
2010
-
Twelve-month outcome after one intravitreal injection of bevacizumab to treat myopic choroidal neovascularization
Retina, Vol. 30, Núm. 10, pp. 1609-1615